Skip to content

The Ultrasound-guided vs Bronchoscopy-guided vs Ultrasound-bronchoscopy-guided Percutaneous Tracheostomy Trial

The Ultrasound-guided Versus Bronchoscopy-guided vs Ultrasound-bronchoscopy-guided Percutaneous Dilational Tracheostomy Trial - Standardization or Customization?

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06226142
Acronym
BRONCUS-PDT
Enrollment
150
Registered
2024-01-26
Start date
2024-01-17
Completion date
2026-01-01
Last updated
2024-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheostomy Complication, Tracheostomy Hemorrhage, Tracheostomy Infection

Brief summary

This trial (BRONCUS) is a randomized one designed to evaluate the overall safety of ultrasound guided compared to bronchoscopy guided compared to ultrasound-bronchoscopy guided percutaneous tracheostomy, in order to find out if universal standardization is required or customized approach can be sufficient.

Detailed description

Enrolled patients will be randomized in a 1:1:1 ratio to ultrasound or bronchoscopy or ultrasound-bronchoscopy arms, and then the procedure related complications and clinical outcomes will be evaluated and compared between the groups. The procedures will be performed according to standardized practices following hospital guidelines.

Interventions

Percutaneous dilatational tracheostomy

Sponsors

Iuliu Hatieganu University of Medicine and Pharmacy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Enrolled patients will be randomized in a 1:1:1 ratio to ultrasound or bronchoscopy or ultrasound-bronchoscopy percutaneous dilatational tracheostomy.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* adult patients (over 18 years old), intubated, mechanically ventilated, and with an indication for a tracheostomy

Exclusion criteria

Patients with contraindications for PDT: * short neck * tracheal deviation * difficult anatomy * previous neck surgery * cervical trauma or inability to perform neck extension * preference for surgical tracheostomy by the patient assistant team * patients unable to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
PDT feasibility/failureDuring PDT - 15-25 minutesConversion to a surgical tracheostomy in any case, associated use of bronchoscopy in the case of ultrasound-guided PDT, associated use of ultrasound in the case of bronchoscopy-guided PDT, or the occurrence of a major complication.

Secondary

MeasureTime frameDescription
Procedure difficultyDuring PDT (an expected average of 15-30 minutes)(1) easy, (2) somewhat difficult, (3) difficult, (4) very difficult, or (5) impossible
ICU mortalityDuring hospital LOS (an expected average of 4 weeks )We will measure ICU mortality at the discharge and 60 days after discharge.
Hospital mortalityDuring hospital LOS (an expected average of 4 weeks)We will measure hospital mortality at the discharge and 60 days after discharge.
Procedure durationDuring PDT (an expected average of 15-30 minutes)We will measure the procedure duration from the point beginning of the procedure and the end of it.
Mechanical ventilationDuring hospital LOS (an expected average of 4 weeks)Days of MV before and after PDT
Minor complication - hypoxemiaDuring PDT (an expected average of 15-30 minutes)A drop in peripheral oxygen saturation \< 90% for more than 2 minutes as measured by pulse oxymeter during the procedure while the patient is of 100% FiO2
Minor complication - hypotensionDuring PDT (an expected average of 15-30 minutes)a drop of MAP\<65 mmHg for less than 5 minutes without the requirement of fluids or vasopressors
Minor complication - Tracheostomy stoma infectionDuring hospital LOS (an expected average of 4 weeks)Tracheostomy stoma infection
Minor complication - Localized minor bleedingDuring PDT (an expected average of 15-30 minutes)Localized minor bleeding
Minor complication - Localized subcutaneous emphysemaDuring PDT (an expected average of 15-30 minutes)Localized subcutaneous emphysema
Lenght of ICU stay(an expected average of 4 weeks)Lenght of ICU stay
Lenght of hospital stay(an expected average of 4 weeks)Lenght of hospital stay
Minor complication - Accidental decannulationDuring hospital LOS (an expected average of 4 weeks)Accidental decannulation

Countries

Romania

Contacts

Primary ContactCatalin Constantinescu, MD, PhD
constantinescu.catalin@ymail.com0040743903224
Backup ContactOlga Grajdieru, MD
olgadoinag@yahoo.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026